• SENSEX 81,442.04
    443.79 (+0.55%)
  • BANKNIFTY 55,760.85
    84.00 (+0.15%)
  • Cochin Shipyard
    2,377.00 2,977.10(%)
  • Garden Reach Sh.
    3,528.00 3,464.85(%)
  • Reliance Power
    59.93 23.26(%)
  • Mazagon Dock
    3,460.00 3,778.00(%)
  • Brainbees Solut.
    410.00 734.25(%)
  • Suzlon Energy
    68.60 86.04(%)
  • Eternal Ltd
    260.15 304.50(%)
  • Tata Motors
    714.00 1,179.05(%)
  • Sika Interplant
    1,350.35 1,125.30(%)
  • Angel One
    3,283.00 3,502.60(%)
  • Data Pattern
    3,208.90 3,654.75(%)
  • Reliance Industr
    1,454.50 1,608.95(%)
  • Bharat Electron
    394.60 393.55(%)
  • Waaree Energies
    2,838.05 1,808.65(%)
  • Newgen Software
    1,335.70 1,795.50(%)
  • Bharat Dynamics
    1,981.00 2,096.00(%)
  • Railtel Corpn.
    464.70 618.00(%)
  • Avantel
    184.50 212.68(%)
  • I R F C
    148.00 229.05(%)
  • Ircon Intl.
    216.70 134.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alivus Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75599.0
  • ISIN : INE03Q201024
1,011.50 -12 (-1.17%)
  • As on 05 Jun 2025 (EOD)

  • Today’s Low

    1,007.40

  • Today’s High

    1,029.90

  • Open

    1,013.30

  • Perv Close

    1,023.50

  • 52W Low

    755.95

  • 52W High

    1,335.10

Key Indicators

  • P/E(TTM)

    25.56

  • Mar.Cap (₹Cr.)

    12,403.94

  • Div & Yield %

    0.49

  • Book Value(₹)

    229.75

  • Debt-Equity Ratio

    -1.17

  • AGM Date

    05-Jun-2025

  • EPS

    39.60

  • P/E Ratio

    25.56

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    12,403.94

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    24.53

  • BV (₹)

    229.70

  • Sales( ₹ in Cr.)

    2,386.88

  • NP (in Cr.)

    485.63

  • NP Var(%)

    3.0

  • Div%

    250.0

  • CPS (₹)

    44.50

  • EPS (₹)

    39.60

  • Traded Value (₹ in Lakhs)

    12,560.29

  • 52 Week High

    1,335.10

  • 52 Week Low

    755.95

  • Price BSE

    1024.0

  • Price NSE

    1,024.00

  • Market Capital( in Cr.)

    12,560.29

  • P/C Ratio

    23.00

  • P/E Ratio

    25.90

  • Price Vs.BV

    39.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,283.21 2,161.22 2,123.21 1,885.17 1,537.31 886.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,283.21 2,161.22 2,123.21 1,885.17 1,537.31 886.42
Other Income 12.04 28.96 14.70 0.81 11.99 0.44
Stock Adjustments 56.57 84.44 -41.32 70.70 4.64 301.59
Total Income 2,351.82 2,274.62 2,096.59 1,956.68 1,553.94 1,188.45
EXPENDITURE :            
Raw Materials 1,025.21 1,068.56 977.96 948.17 668.66 633.56
Power and Fuel Cost 112.46 115.60 100.92 74.19 76.75 57.81
Employee Cost 258.16 180.18 168.72 149.13 142.28 106.28
Other Manufacturing Expenses 163.64 137.17 124.04 107.32 108.04 77.09
Selling and Administration Expenses 64.12 65.47 48.64 48.50 42.05 44.20
Miscellaneous Expenses 41.97 36.39 45.56 37.49 32.22 21.35
Employee Benefit Expenses 258.16 180.18 168.72 149.13 142.28 106.28
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,665.54 1,603.36 1,465.83 1,364.80 1,069.99 940.29
Operating Profit 686.29 671.25 630.76 591.89 483.96 248.17
Interest 1.55 0.55 27.96 87.55 33.52 0.61
Gross Profit 684.74 670.70 602.80 504.34 450.44 247.56
Depreciation 53.45 42.09 37.88 33.39 29.37 19.26
Profit Before Tax 631.29 628.61 564.92 470.95 421.07 228.30
Current Tax 152.21 150.61 137.63 112.75 98.54 25.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.19 11.04 8.57 6.62 9.43 6.81
Reported Net Profit 470.89 466.96 418.72 351.58 313.10 195.59
Extraordinary Items -0.53 -0.41 -0.55 -0.44 -0.91 -0.54
Adjusted Net Profit 471.42 467.37 419.27 352.02 314.01 196.13
Adjustment below Net Profit -5.46 -0.29 -19.50 -0.53 0.47 -108.02
P & L Balance brought forward 1,102.06 1,021.35 750.79 399.73 86.17 -1.41
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 275.69 385.96 128.65 0.00 0.00 0.00
P & L Balance carried down 1,291.80 1,102.06 1,021.35 750.79 399.73 86.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,125.00 2,100.00 1,050.00 0.00 0.00 0.00
Dividend Per Share(Rs) 22.50 42.00 21.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 38.43 38.11 34.17 358.76 1,597.44 997.92
Earnings Per Share(Adj)-Unit Curr 38.43 38.11 34.17 - - -
Book Value 190.35 174.51 167.66 768.11 2,049.45 449.62
Book Value(Adj)-Unit Curr 190.35 174.51 167.66 - - -

Shareholding Pattern

  • Promoter Group

    74.99%

  • Public Share Holding

    25.01%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,896,285 74.99 91,896,285 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 91,896,285 74.99 91,896,285 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,051,382 6.57 8,051,382 71
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 266,019 0.22 266,019 3
Mutual Funds / UTI 4,402,456 3.59 4,402,456 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,687,137 1.38 1,687,137 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 14,406,994 11.76 14,406,994 105
2] Non Institution
Bodies Corporate 2,190,415 1.79 2,190,415 972
Clearing Members 46 0.00 46 5
Directors of their Relatives 1,000 0.00 1,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 805,734 0.66 805,734 2,758
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 321,635 0.26 321,635 2,631
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 909,763 0.74 909,763 6
Individuals holding nominal share capital up to Rs. 1 lakh 11,962,096 9.76 11,962,096 135,489
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 43,084 0.04 43,084 9
Others 0 0.00 0 0
Sub Total 16,233,773 13.25 16,233,773 141,871
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 122,537,052 100.00 122,537,052 141,977

Company Background

Alivus Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alivus Life Sciences Ltd
  • BSE Code : 75599.0
  • ISIN : INE03Q201024

  • Incorporation Year

    2011

  • Registered Office

    Plot No. 170-172 Chandramouli
    Industrial Est.Mohol Bazarpeth, Solapur,
    Maharashtra-413213

  • Telephone

    91-2189-234456/234246

  • FAX

  • Chairman

    HIREN KARSANBHAI PATEL

  • Managing Director

    Yasir Yusufali Rawjee

  • Company Secretary

    Rudalf Corriea

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Alivus Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alivus Life 1,012.30 2,295.26 2,283.21 25.56 27.94
Abbott India 31,699.95 6,097.18 5,848.91 47.62 44.71
Astrazeneca Phar 9,891.10 1,330.33 1,295.53 213.63 33.26
P & G Health Ltd 5,576.75 1,166.89 1,151.26 36.85 39.76
Glaxosmi. Pharma 3,459.70 3,866.05 3,723.49 63.77 58.72
Cipla 1,489.65 17,645.00 16,574.34 23.33 20.10
Amrutanjan Healt 723.80 437.58 421.23 41.17 20.84
Guj. Themis Bio. 329.70 174.19 169.82 73.59 44.82
Fermenta Biotec. 323.00 315.24 307.09 14.06 4.10
Bliss GVS Pharma 139.55 638.96 605.46 21.31 11.19
Ambalal Sarabhai 36.84 11.70 3.81 34.11 1.92